Final hours! Save up to 50% OFF InvestingProCLAIM SALE

BRIEF-Moderna's Covid-19 vaccine candidate is now the most advanced in Canada's regulatory process, no date yet for a decision - senior Health Canada official

Published 2020-12-09, 01:02 p/m

Dec 9 (Reuters) -

* MODERNA'S COVID-19 VACCINE CANDIDATE IS NOW THE MOST ADVANCED IN CANADA'S REGULATORY PROCESS, NO DATE YET FOR A DECISION - SENIOR HEALTH CANADA OFFICIAL

* CANADA'S AUTHORISATION OF PFIZER'S CORONAVIRUS VACCINE COVERS MULTIPLE LOTS, MULTIPLE PRODUCTION SITES - SENIOR HEALTH CANADA OFFICIAL

* SENIOR HEALTH CANADA OFFICIAL, ASKED ABOUT ADVERSE SIDE-EFFECTS TO PFIZER'S COVID-19 VACCINE IN BRITAIN, SAYS WE KNOW WITH ALL VACCINES THERE IS A RISK OF AN ALLERGIC REACTION

* HEALTH CANADA IS LOOKING AT REPORTS OF ADVERSE REACTIONS TO PFIZER VACCINE IN BRITAIN TO SEE IF THERE ARE ANY IMPLICATIONS FOR CANADA - HEALTH CANADA OFFICIAL

* HEALTH CANADA IS ADVISING PEOPLE WHO HAVE PREVIOUSLY SHOWN ADVERSE REACTIONS TO ANY OF THE INGREDIENTS OF THE PFIZER VACCINE NOT TO BE INOCULATED NOW - HEALTH CANADA OFFICIAL

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.